Rush Elizabeth Marie, Ogburn Anna L, Monroe Denise
Birmingham Zoo, Inc., 2630 Cahaba Road, Birmingham, Alabama 35223, USA.
J Zoo Wildl Med. 2011 Jun;42(2):263-76. doi: 10.1638/2009-0080.1.
A 24-yr-old, male western lowland gorilla (Gorilla gorilla gorilla) was diagnosed with congestive heart failure using transesophageal and transthoracic echocardiology. New York Heart Association (NYHA) Class III was assigned to the severity of the condition. Over 16 mo, this progressed to NYHA Class IV despite increasing medical therapy. Repeated evaluations suggested that implantation of a cardiac resynchronization therapy device with a defibrillator (CRT-D) could benefit this animal based on clinical signs and underlying evidence of dyssynchrony and suspected fibrotic myocardial disease. Surgical implantation of leads into the right atrium, right ventricle, and left ventricle was accomplished. The CRT-D device was placed under the thoracic pectoral muscles during an initial surgical procedure. Improvement in the gorilla's clinical condition after implantation of the CRT-D device was immediate and dramatic. Subsequent scanning of the device was accomplished through operant conditioning. The data from these device interrogations included stored and real-time cardiac data, which were used to minimize recognized environmental stressors and change device settings. Over 4 yr, case management was critical to successful device use in treatment of the clinical disease. This involved medications, training for device interrogation, exercise to increase activity and improve body condition, and phlebotomy attempts. Dietary management was necessary to manipulate caloric and sodium intake and encourage medication compliance. Cardiac resynchronization therapy device implantation, although requiring specialized equipment and surgical skill, appears to be a viable option for treatment of fibrosing cardiomyopathy with systolic dysfunction in gorillas refractory to medical management. In addition to treatment, this device provides cardiovascular data at rest that could allow for early diagnosis and treatment of gorillas with this and other cardiac conditions in the future. This describes the comprehensive medical, husbandry, and training techniques necessary to successfully manage this intense clinical case in conjunction with intracardiac device therapy.
一只24岁的雄性西部低地大猩猩(Gorilla gorilla gorilla)通过经食管和经胸超声心动图被诊断为充血性心力衰竭。根据纽约心脏协会(NYHA)分级,该病症的严重程度为III级。在16个多月的时间里,尽管加大了药物治疗力度,但病情仍进展至NYHA IV级。反复评估表明,基于临床症状、潜在的不同步证据以及疑似纤维化心肌病,植入带有除颤器的心脏再同步治疗设备(CRT-D)可能会使这只动物受益。已成功将电极导线植入右心房、右心室和左心室。在首次手术过程中,将CRT-D设备置于胸大肌下方。植入CRT-D设备后,大猩猩的临床状况立即得到显著改善。随后通过操作性条件反射完成了对该设备的扫描。这些设备询问的数据包括存储的和实时的心脏数据,这些数据被用于尽量减少已识别的环境应激源并更改设备设置。在4年多的时间里,病例管理对于成功使用该设备治疗临床疾病至关重要。这包括药物治疗、设备询问培训、增加活动量和改善身体状况的运动以及放血尝试。饮食管理对于控制热量和钠的摄入以及鼓励药物依从性是必要的。心脏再同步治疗设备植入虽然需要专业设备和手术技能,但对于药物治疗无效的患有收缩功能障碍的纤维化心肌病大猩猩来说,似乎是一种可行的治疗选择。除了治疗之外,该设备还能提供静息时的心血管数据,这可能有助于未来对患有这种及其他心脏疾病的大猩猩进行早期诊断和治疗。本文描述了成功管理这一复杂临床病例并结合心内设备治疗所需的综合医疗、饲养和训练技术。